Money
Samplix Raises €25 Million to Expand Antibody Discovery Platform
Danish biotech firm Samplix has secured €25 million in the first close of a funding round to scale its antibody discovery technology and expand its market presence.
October 28, 2026, 09:31 AM·EU-Startups
